A Clinical Trial to Evaluate the Safety and Immunogenicity of BG505 MD39.3, BG505 MD39.3 gp151, and BG505 MD39.3 gp151 CD4KO HIV Trimer mRNA Vaccines in Healthy, HIV-uninfected Adult Participants

计划入组 108 人 · 首次发布于 2022 年 2 月 1 日

Prospective, Comparative Assessment of Alveolar Bone Augmentation Using GUIDOR® Membrane in the Bound Edentulous Space

计划入组 6 人 · 首次发布于 2015 年 3 月 12 日

A Study of GC203 TIL in Advanced Gynecologic Tumors (10hospital)

计划入组 26 人 · 首次发布于 2022 年 7 月 21 日

BG505 MD39.3 gp151 CD4KO

BG505 MD39.3 gp151 CD4KO mRNA

Trimer-6931

Telix Pharmaceuticals

Australia

MiMedx

United States

Comstock Metals Ltd

Australia

Urticaria Emerges as Concern in Phase 1 Trial of HIV mRNA Vaccines

IAVI Initiates Phase 1 Trial of Novel mRNA HIV Vaccine Targeting Broadly Neutralizing Antibodies

Breakthrough Antibody MARV16 Shows 40-100 Fold Increased Potency Against Marburg Virus